New shingles shot shows promise in Mid-Stage trial
Prevention
Not yet recruiting
This study tests a new shingles vaccine in 135 healthy adults aged 50 and older. Researchers will compare the immune response and safety of the new vaccine against an existing one to find the best dose. The goal is to prevent shingles, a painful rash caused by the chickenpox viru…
Phase: PHASE2 • Sponsor: CHA Vaccine Institute Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC